Opiant Pharmaceuticals (OPNT) executive Skolnick sold 627 shares for $7,430 at $11.85
Insider transactions reported
Phil Skolnick (executive at Opiant Pharmaceuticals Inc., OPNT) reported that they sold 627 shares for $7,430 at $11.85 on Jul 14, 2022. After these transactions the filing shows 23,818 shares held directly.
- Reporting person
- Skolnick Phil
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 14, 2022 | Open-market sale (S) | Common Stock1, 2 | -627 | $11.85 | $7,430 | 23,818 direct |
Holdings before and after
- Common Stock: 24,445 to 23,818 direct
Footnotes from the filing
- 1. These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units.
- 2. This transaction was executed in multiple trades at prices ranging from $11.03 to $11.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Skolnick report in this OPNT Form 4?
Phil Skolnick (executive at Opiant Pharmaceuticals Inc., OPNT) reported that they sold 627 shares for $7,430 at $11.85 on Jul 14, 2022. After these transactions the filing shows 23,818 shares held directly.
How many OPNT shares does Skolnick hold after this filing?
The filing shows 23,818 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this OPNT insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for OPNT
Earlier insider filings at OPNT
- Jul 15, 2022SEC Form 4: O'Toole David D sold $8,647 worth of shares (779 units at $11.10), decreasing direct ownership by 2% to 36,804 units (withholding tax)
- Jul 15, 2022SEC Form 4: Gorman Brian sold $7,712 worth of shares (691 units at $11.16), decreasing direct ownership by 2% to 33,747 units (tax liability)
- Jul 15, 2022SEC Form 4: Crystal Roger sold $24,953 worth of shares (2,246 units at $11.11), decreasing direct ownership by 3% to 82,909 units to cover withholding tax
- Jun 29, 2022SEC Form 4: Ellison Mark Jason Heath was granted 2,000 shares, increasing direct ownership by 10% to 21,636 units
- Jun 29, 2022SEC Form 4: Crystal Roger was granted 6,667 shares, increasing direct ownership by 8% to 85,155 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow OPNT and get a push notification the moment its next story breaks.